Header Logo

Wilson Mertens

Concepts (106)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
6
2022
1036
1.170
Why?
Insulin Resistance
1
2022
373
0.710
Why?
Spirituality
2
2005
42
0.530
Why?
Weight Gain
2
2022
178
0.490
Why?
Hospital Design and Construction
1
2013
2
0.480
Why?
Medical Order Entry Systems
1
2012
46
0.460
Why?
Medication Errors
1
2012
109
0.440
Why?
Norovirus
1
2011
6
0.430
Why?
Virus Shedding
1
2011
19
0.430
Why?
Cooperative Behavior
1
2013
204
0.420
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2011
42
0.410
Why?
Diarrhea
1
2011
66
0.410
Why?
Patient Participation
1
2013
185
0.410
Why?
Neoplasms
3
2005
1058
0.400
Why?
Quality Assurance, Health Care
1
2012
228
0.400
Why?
Patient Care Team
1
2012
275
0.390
Why?
Protestantism
2
2005
4
0.340
Why?
Catholicism
2
2005
4
0.330
Why?
Therapeutic Touch
1
2007
2
0.330
Why?
Stereotaxic Techniques
1
2007
19
0.330
Why?
Pain Management
1
2007
121
0.280
Why?
Neoplasms, Multiple Primary
1
2004
28
0.260
Why?
Pastoral Care
1
2004
1
0.260
Why?
Hospices
1
2004
21
0.260
Why?
Carcinoma, Lobular
1
2004
20
0.260
Why?
Neoplasms, Second Primary
1
2004
33
0.260
Why?
Pain
1
2007
309
0.260
Why?
Hospice Care
1
2004
37
0.260
Why?
Carcinoma in Situ
1
2004
33
0.260
Why?
Carcinoma, Ductal, Breast
1
2004
42
0.260
Why?
Nausea
1
2003
35
0.240
Why?
Vomiting
1
2003
39
0.240
Why?
Body Mass Index
2
2022
852
0.230
Why?
Female
11
2022
26332
0.220
Why?
Antineoplastic Agents
2
2007
533
0.220
Why?
Attitude to Health
1
2004
291
0.220
Why?
Length of Stay
1
2004
627
0.210
Why?
Regression Analysis
3
2007
456
0.200
Why?
Massachusetts
3
2013
2021
0.200
Why?
Chemotherapy, Adjuvant
2
2012
75
0.190
Why?
Practice Guidelines as Topic
1
2003
591
0.180
Why?
Humans
13
2022
49658
0.170
Why?
Insulin
1
2022
658
0.170
Why?
Middle Aged
7
2011
13448
0.160
Why?
Prospective Studies
1
2022
2520
0.140
Why?
Physician Incentive Plans
1
2013
9
0.130
Why?
Hematologic Neoplasms
1
2013
32
0.120
Why?
Medical Oncology
1
2013
40
0.120
Why?
Multivariate Analysis
2
2007
835
0.120
Why?
Anxiety
2
2007
310
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2007
284
0.120
Why?
Organizational Case Studies
1
2013
42
0.120
Why?
Sex Factors
2
2005
850
0.110
Why?
Fatal Outcome
1
2011
99
0.100
Why?
Adult
5
2007
13328
0.100
Why?
Interviews as Topic
1
2012
422
0.100
Why?
Immunosuppressive Agents
1
2011
224
0.100
Why?
Adolescent
3
2005
5322
0.090
Why?
Quality of Health Care
1
2013
471
0.090
Why?
Surveys and Questionnaires
2
2007
2285
0.080
Why?
Male
5
2011
23131
0.080
Why?
Single-Blind Method
1
2007
109
0.080
Why?
Aged
4
2005
10869
0.080
Why?
Risk Factors
2
2007
4244
0.080
Why?
Pain Measurement
1
2007
248
0.070
Why?
Biopsy
1
2007
326
0.070
Why?
Love
1
2005
1
0.070
Why?
Breast
1
2007
165
0.070
Why?
Fear
1
2005
51
0.070
Why?
Morale
1
2004
4
0.070
Why?
Religion and Psychology
1
2004
15
0.060
Why?
Anger
1
2004
27
0.060
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
104
0.060
Why?
Longitudinal Studies
1
2007
1041
0.060
Why?
Emotions
1
2005
181
0.060
Why?
Data Interpretation, Statistical
1
2004
186
0.060
Why?
Feedback
1
2003
82
0.060
Why?
Neoplasm Staging
1
2004
372
0.060
Why?
Health Services Research
1
2004
252
0.060
Why?
Proportional Hazards Models
1
2004
627
0.060
Why?
Patient Satisfaction
1
2005
364
0.060
Why?
Mastectomy
1
2022
50
0.060
Why?
Mastectomy, Segmental
1
2022
42
0.060
Why?
Communication
1
2005
442
0.050
Why?
Program Evaluation
1
2004
463
0.050
Why?
Treatment Outcome
2
2007
3888
0.050
Why?
Neoplasm Recurrence, Local
1
2022
245
0.050
Why?
Patient Compliance
1
2003
334
0.050
Why?
Lung Neoplasms
1
2005
437
0.050
Why?
Logistic Models
1
2004
1159
0.050
Why?
Mammography
1
2022
241
0.050
Why?
Obesity
1
2007
1125
0.040
Why?
Cohort Studies
1
2004
2064
0.040
Why?
Time Factors
1
2004
3127
0.040
Why?
Retrospective Studies
1
2004
4517
0.030
Why?
Reimbursement, Incentive
1
2013
28
0.030
Why?
Societies, Medical
1
2013
215
0.030
Why?
Quality Improvement
1
2013
321
0.020
Why?
Celecoxib
1
2005
15
0.020
Why?
Taxoids
1
2005
26
0.020
Why?
Infusions, Intravenous
1
2005
153
0.020
Why?
Disease-Free Survival
1
2005
177
0.020
Why?
Pyrazoles
1
2005
59
0.020
Why?
Sulfonamides
1
2005
115
0.020
Why?
Administration, Oral
1
2005
301
0.020
Why?
United States
1
2013
6232
0.010
Why?
Mertens's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (106)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_